Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial

Title
Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial
Authors
Keywords
-
Journal
Publisher
The Endocrine Society
Online
2020-02-13
DOI
10.1210/clinem/dgaa049

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started